Skip to main content
Tomas Holmlund, MD, Neurology, Amherst, NY

Tomas Holmlund MD ,FAAN

Movement Disorder, Neuromuscular Medicine


Medical Director, Neuromuscular Center, Dent Neurologic Institute

Join to View Full Profile
  • 3980 Sheridan DrSuite 200Amherst, NY 14226

  • Phone+1 716-250-2000

  • Fax+1 716-636-1365

Dr. Holmlund is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University at Buffalo
    University at BuffaloResidency, Neurology, 1986 - 1990
  • SUNY at Buffalo Graduate Medical-Dental Education Consortium (Millard Fillmore)
    SUNY at Buffalo Graduate Medical-Dental Education Consortium (Millard Fillmore)Internship, Internal Medicine, 1985 - 1986
  • Other
    OtherClass of 1985

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1989 - 2025
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Medical Leader Award Muscular Dystrophy Assocation- Western New York, 2015
  • Top 50 Physicians Business First's Healthcare, 2013
  • CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Gerstmann-Straussler-Scheinker syndrome masquerading as multiple sclerosis  
    A Kurzweil, E Lindzen, T Holmlund & B Weinstock-Guttman, Journal of the Neurological Sciences, 1/1/2011
  • ALS: Family caregivers needs and quality of life  
    Mary Tederous Williams, Tomas Holmlund et al, Amyotrophic Lateral Sclerosis, 1/1/2008
  • Normal pressure hydrocephalus  
    Holmlund, T., Clev. Clin. J. Med., 1/1/2006
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Cervical Dystonia Patient Registry for Observation of Onabotulinumtoxin A Efficacy (CD PROBE), Baseline Demographics and Clinical Characteristics.
    CD Probe Study Group, T Holmlund, et al, AAPM&R (American Academy of Physical Medicine and Rehabilitation), Annual Assembly, National Harbor, MD, 1/1/2013
  • Cervical Dystonia Patient Registry for Observation of Onabotulinumtoxin A Efficacy (CD PROBE); Pain at baseline.
    CD Probe Study Group, T Holmlund, et al, World Congress of Neurology, Vienna, Austria, 1/1/2013
  • Cervical dystonia subtypes. Baseline results from the cervical dystonia patient registry for observation of onabotulinumtoxin efficacy (CD Probe).
    CD Probe Study Group, 16th International Congress of Parkinson's Disease and Movement Disorders, Dublin, Ireland, 1/1/2012
  • Join now to see all

Lectures

  • Profound impairment of consciousness: Clinical and ethical perspective. 
    1/1/2008
  • The Needs and QoL of ALS family caregivers. 
    Lisbon, Portugal - 1/1/2006
  • Diabetic neuropathy. 
    1/1/2002
  • Join now to see all

Other

  • Strategies for enzyme uptake modification to facilitate enzyme uptake. 
    Stahl P, Holmlund T and Holt G, Adv. In Treatment of Inborn Errors of Metabolism (Watts RWE ed), pp. 233-243
    1/1/1981

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: